116491 ⎘
Hydrolases acting on ester bonds (3.1); Endoribonucleases producing 3'-phosphomonoesters (3.1.27) Pancreatic ribonuclease (3.1.27.5)
METHODS FOR TREATING ACUTE CORONARY SYNDROME USING APOA-1 FUSION PROTEINS
#2Therapeutic Nuclease Compositions and Methods
#3THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
#4POLYNUCLEOTIDES ENCODING APOA-1 FUSION POLYPEPTIDES
#5NUCLEIC ACID MOLECULES ENCODING NUCLEASE-ALBUMIN FUSION PROTEINS
#6OPTIMIZED BINUCLEASE FUSIONS AND METHODS
#7OPTIMIZED BINUCLEASE FUSIONS AND METHODS
#8KITS AND METHODS FOR QUANTITATIVE ASSESSMENT AND ENRICHMENT OF EXTRACHROMOSOMAL CIRCULAR DNA
#9FREEZE DRIED VIRAL NANOPARTICLE CONSTRUCTS
#10NANOVESICLES DERIVED FROM CELL MEMBRANE, AND USE THEREOF
#11ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS
#12Freeze dried viral nanoparticle constructs
#13POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYN-DROMES
#14THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
#15POLYNUCLEOTIDES ENCODING APOA1-RNASE FUSION POLYPEPTIDES
#16VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE AND/OR AMPHINASE
#17Combination chemotherapy for the treatment of cancer
#18Optimized binuclease fusions and methods
#19Polynucleotides encoding APOA1-PON1 fusion polypeptides
#20Enzymatic synthesis of kavalactones and flavokavains
#21Enzymatic synthesis of kavalactones and flavokavains
#22Therapeutic Nuclease Compositions and Methods
#23Nucleic acid molecules encoding nuclease-albumin fusion proteins
#24Nanovesicles derived from cell membrane, and use thereof
#25PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS, PARTICULARLY HIV
#26RNA silencing nanozymes
#27Freeze dried viral nanoparticle constructs
#28CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES
#29COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
#30Enzymatic synthesis of kavalactones and flavokavains
#31OPTIMIZED BINUCLEASE FUSIONS AND METHODS
#32Use of electrochemical devices or systems comprising redox-functionalized electrodes for bioseparation and biocatalysis
#33Combination chemotherapy for the treatment of cancer
#34Therapeutic nuclease compositions and methods
#35Technology for the Preparation of Microparticles
#36PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF A HIGHLY CONTROLLED AND STABLE DOSE OF NANOPARTICLES OR BIOMACROMOLECULE SUSPENSIONS
#37APOA-1 FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS
#38Therapeutic nuclease compositions and methods
#39Cell membrane-derived nanovesicles and use thereof
#40Technology for the Preparation of Microparticles
#41Prophylactic protection against viral infections, particularly HIV
#42Methods and compositions for modulating immune tolerance
#43Technology for the Preparation of Microparticles
#44Process for bone tissue decellularization
#45NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS
#46Therapeutic nuclease-albumin fusions and methods
#47Technology for the Preparation of Microparticles
#48Nanocomplexes of modified peptides or proteins
#49BORONATE-MEDIATED DELIVERY OF MOLECULES INTO CELLS
#50Antiviral pharmaceutical for topical administration
#51Compositions and Methods for Treatment of Stroke
#52Bioreversible boronates for delivery of molecules into cells
#53Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
#54Technology for the Preparation of Microparticles
#55GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS
#56METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#57Therapeutic ribonucleases
#58Therapeutic nuclease compositions and methods
#59Therapeutic nuclease compositions and methods
#60Methods and compositions for modulating immune tolerance
#61Cytotoxic ribonuclease variants
#62Therapeutic nuclease compositions and methods
#63BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE
#64BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH
#65Cytotoxic ribonuclease variants
#66Therapeutic ribonucleases
#67Therapeutic nuclease compositions and methods
#68Glycopegylation methods and proteins/peptides produced by the methods
#69Technology for the Preparation of Microparticles
#70Stabilized protease-containing solutions for purifying RNA-free DNA
#71Therapeutic ribonucleases
#72Method for delivering cytotoxic activity to cells
#73Methods and compositions for modulating immune tolerance
#74Nucleic acid constructs encoding cytotoxic ribonuclease variants
#75Therapeutic ribonucleases
#76Glycopegylation methods and proteins/peptides produced by the methods
#77RIBONUCLEASE AND THIAZOLIDINEDIONE COMPOUNDS AND THEIR USE IN METHODS TO TREAT CANCER
#78Technology for the Preparation of Microparticles
#79Compositions and methods for ribonuclease-based therapeutics
#80Methods and compositions for the treatment of cancer
#81Glycopegylation methods and proteins/peptides produced by the methods
#82Cytotoxic ribonuclease variants
#83Composition containing eosinophil cationic protein
#84Non-natural ribonuclease conjugates as cytotoxic agents
#85Eosinophil Major Basic Protein as a natural heparanase-inhibiting protein, compositions, methods and uses thereof